Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Marina Mencinger"'
Autor:
Enrique Grande, Aristotelis Bamias, Matthew D. Galsky, Eiji Kikuchi, Ian D. Davis, José Ángel Arranz, Arash Rezazadeh Kalebasty, Xavier Garcia del Muro, Se Hoon Park, Ugo De Giorgi, Boris Alekseev, Marina Mencinger, Kouji Izumi, Javier Puente, Jian-Ri Li, Sandrine Bernhard, Alan Nicholas, Julie Telliez, Maria De Santis
Publikováno v:
European Urology Open Science, Vol 58, Iss , Pp 28-36 (2023)
Standard-of-care first-line treatment for metastatic urothelial carcinoma (mUC) is platinum-based chemotherapy (CTx). Maintenance immunotherapy is a treatment option for patients without progressive disease (PD) after induction CTx. IMvigor130 was a
Externí odkaz:
https://doaj.org/article/23174f8611b2473d8705753cdcab834f
Autor:
ANJA KOVAČ, Erika Matos, Cvetka Grašič Kuhar, Marina Čakš, Tanja Ovčariček, Marina Mencinger, Mojca Humar, Simona Borštnar
Publikováno v:
Cancer Treatment and Research Communications, Vol 25, Iss , Pp 100201- (2020)
Background: Selective cyclin-dependent kinases 4/6 inhibitors (CDKi) have become the standard of care in patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancer (ABC). We performed retrospective analysis in patients treated
Externí odkaz:
https://doaj.org/article/c7467637b3a9492d8d06b04ddfa13ccb
Autor:
Marina Mencinger
Publikováno v:
Onkologija, Vol 22, Iss 1, Pp 24-27 (2018)
Zaviralci tirozin-kinaz so multitarčna zdravila, ki prek zaviranja različnih celičnih procesov učinkujejo pri več vrstah rakavih boleznih. Čeprav so stranski učinki ob zaviralcih tirozinskih kinaz v splošnem prenosljivi, pa so lahko tudi resn
Externí odkaz:
https://doaj.org/article/5ebb9a2c10f64a4c9f374377d8efc464
Autor:
Marina Mencinger, Jasna But-Hadžić
Publikováno v:
Onkologija, Vol 18, Iss 1, Pp 4-8 (2014)
Rak dojke pri mladih bolnicah je redek pojav. Uspešno zdravljenje te bolezni omogoča večini mladih bolnic dolgo preživetje. Pomemben vidik kakovosti življenja je nedvomno ohranjanje plodnosti, posebno ob zavedanju, da je starost žensk ob prvem
Externí odkaz:
https://doaj.org/article/aee6465790bc4224a00310dd38eb2676
Publikováno v:
Onkologija, Vol 14, Iss 1, Pp 6-10 (2010)
Ni abstrakta.
Externí odkaz:
https://doaj.org/article/b8bae1dfcf924e31b847ffa98c9c96de
Autor:
Marina Mencinger, Peter Černelč
Publikováno v:
Zdravniški Vestnik, Vol 77, Iss SUPPI (2008)
BACKGROUND Bacterial and fungal infections are the most common complication in patients withhematological diseases treated with chemotherapy. Autologous hematopoietic stem cell transplantation is the most effective treatment of patients with multiple
Externí odkaz:
https://doaj.org/article/bc442be50e28411d8ed3b913d65eac2e
Publikováno v:
Zdravniški Vestnik, Vol 75, Iss 2 (2006)
Background: Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in gene encoding cystic fibrosis transmembrane regulator (CFTR) protein. Over 1400 mutations found in the gene contribute to the complexity of the CF phenotypes ra
Externí odkaz:
https://doaj.org/article/2b8307103be745228874f1312f6edbcf
Autor:
Prevodnik, Cvetka Grašič Kuhar, Jernej Silvester, Marina Mencinger, Tanja Ovčariček, Maja Čemažar, Simona Miceska, Živa Modic, Anamarija Kuhar, Tanja Jesenko, Veronika Kloboves
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3397
Liquid biopsy is becoming an important source of new biomarkers during the treatment of metastatic cancer patients. Using size-based microfluid technology, we isolated circulating tumor cells (CTCs) from metastatic breast cancer patients to evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::185e05ae9e405d9a5f20193d70259ff1
Publikováno v:
Radiology and Oncology, Vol 55, Iss 4, Pp 491-498 (2021)
Radiology and Oncology
Radiology and Oncology
Background Atezolizumab, a programmed-death ligand-1 (PD-L1) inhibitor, is a novel treatment option for patients with metastatic urothelial cancer (mUC). Clinical prognostic factors, survival outcomes, and the safety of patients with mUC treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db1e819bd0257525e0567e035c9d436c
https://doi.org/10.2478/raon-2021-0021
https://doi.org/10.2478/raon-2021-0021
Autor:
Christiane Thallinger, Peter Berzinec, Emina Bicakcic, Adelina Dan, Gabriella Fabian, Laurentia Nicoletta Gales, Cvetka Grasic Kuhar, Urska Janzic, Zsusanna Kahan, Marina Mencinger, George Penthedourakis, Joseph Sgouros, Luka Simetic, Daniela Sirbu, Milan Vosmik, Anna Wrona, Christoph Zielinski
Publikováno v:
Wiener Klinische Wochenschrift, pp. 1-8, 2022.
Summary Purpose To establish a transborder virtual tumor board (VTB) fostering state-of-the-art management of cancer patients by exchanging knowledge and expertise among oncologists in Central and Southeastern Europe (CEE). Methods We established and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ab6af784007664016b4d3848c8998af
https://dirros.openscience.si/Dokument.php?id=19402&dn=
https://dirros.openscience.si/Dokument.php?id=19402&dn=
